3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
CNS
1
Conditions
Head and Neck Neoplasms
3
Motor Activity
2
Fatigue
2
Uterine Cervical Neoplasms
1
Trismus
1
Sarcoma
1
Pancreatic Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Bronchogenic
1
Brain Neoplasms
1
Accessory Nerve Injuries
1
Interventions
Magnetic Resonance Spectroscopy
6
Radiotherapy
3
Fluorodeoxyglucose F18
3
entrectinib
2
IFL protocol
2
FAPI-46
2
Cisplatin
2
Bevacizumab
2
tipifarnib
1
regorafenib
1
pembrolizumab
1
fluoromisonidazole
1
entinostat
1
cc-486
1
brodalumab
1
alectinib
1
aflibercept
1
Triiodothyronine
1
Trastuzumab
1
Thyroxine
1
Thiotepa
1
Thalidomide
1
Tamoxifen
1
Ritonavir
1
Quality of Life
1
Psychology, Positive
1
Proton Therapy
1
Peripheral Blood Stem Cell Transplantation
1
Patient-Specific Modeling
1
Patient Reported Outcome Measures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Exercise Therapy
×
Head & Neck
×
Clear all
NCT04517019
2020-08-18
OnkoFit II
University Hospital Tuebingen
Phase NA
Unknown
201 enrolled